Results 131 to 140 of about 188,451 (293)

Backbone NMR resonance assignment of the Abelson kinase domain in complex with imatinib [PDF]

, 2018
Imatinib (Glivec or Gleevec) potently inhibits the tyrosine kinase activity of BCR-ABL, a constitutively activated kinase, which causes chronic myelogenous leukemia (CML).
Cowan-Jacob, Sandra, Fendrich, Gabriele, Grzesiek, Stephan, Jahnke, Wolfgang, Manley, Paul, Strauss, André, Vajpai, Navratna   +6 more
core  

Chronic Myelogenous Leukemia [PDF]

Deutsches Ärzteblatt international, 2010
Bubnoff, Nikolas von, Duyster, Justus
  +4 more sources

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia. [PDF]

ADMET DMPK, 2023
Janani G, Girigoswami A, Girigoswami K.
europepmc   +1 more source

Data from Efficacious Immune Therapy in Chronic Myelogenous Leukemia (CML) Recognizes Antigens That Are Expressed on CML Progenitor Cells

, 2023
Melinda A. Biernacki, Ovidiu Marina, Wandi Zhang, Fenglong Liu, Ingmar Bruns, Ann Cai, Donna Neuberg, Christine Canning, Edwin P. Alyea, Robert J. Soiffer, Vladimir Brusić, Jerome Ritz, Catherine J. Wu   +12 more
openalex   +1 more source

Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.

Journal of Clinical Investigation, 2016
Yanli Jin, Jingfeng Zhou, Fang Xu, Bei Jin, L. Cui, Yun Wang, X. Du, Juan Li, Peng Li, R. Ren, Jingxuan Pan   +10 more
semanticscholar   +1 more source

Second Generation Tyrosine Kinase Inhibitors Combined With Allogeneic Hematopoietic Stem Cell Transplantation Improve the Prognosis of Patients with Chronic Myelogenous Leukemia in Blast Crisis

, 2017
Zhengping Yu, Jia hua Ding, Aining Sun, Zheng Ge, Baoan Chen, Wenduo He   +5 more
openalex   +1 more source

Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report [PDF]

, 2019
Shoko Ochiai, Yuji Sato, Akihiro Minakawa, Akihiro Fukuda, Shouichi Fujimoto   +4 more
openalex   +1 more source

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Blood, 2016
Wei Wang, J. Cortes, G. Tang, J. Khoury, Sa A. Wang, C. Bueso-Ramos, Joseph A. DiGiuseppe, Zi Chen, H. Kantarjian, L. Medeiros, Shimin Hu   +10 more
semanticscholar   +1 more source

PHILADELPHIA CHROMOSOME

Gomal Journal of Medical Sciences, 2017
Philadelphia (Ph’) chromosome is an abnormally short chromosome 22 formed as a result of translocation between chromosome 9 and 22. As a result the ABL gene from chromosome 9 joins the BCR gene on chromosome 22.
Habibullah Khan
doaj  

Management of chronic myelogenous leukemia with COVID-19 and hepatitis B. [PDF]

Front Oncol, 2023
Yu T, Li W, Yu T.
europepmc   +1 more source